West Pharmaceutical Services, Inc. (WST) NYSE
312.22
-4.076(-1.29%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 19.89B |
| Enterprise Value | 19.52B |
| P/E Ratio | 41.42 |
| PEG Ratio | 2.42 |
| Price/Sales Ratio | 6.85 |
| Price/Book Ratio | 7.52 |
| Enterprise/Revenue | 6.78 |
| Enterprise/EBITDA | 27.35 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.17 |
| Operating Margin | 0.21 |
Management Effectiveness
| Return On Assets | 0.13 |
| Return On Equity | 0.18 |
Income Statement
| Revenue | 3.07B |
| Revenue/Share | 44.73 |
| Gross Profit | 1.1B |
| EBITDA | 723.6M |
| Net Income | 493.7M |
| Diluted EPS | 6.8 |
Balance Sheet
| Total Cash | 521.4M |
| Total Cash/Share | 7.24 |
| Total Debt | 316.2M |
| Total Debt/Equity | 0.11 |
| Current Ratio | 2.71 |
| Book Value Per Share | 41.53 |
Price History
| 52-Week Change | 49.09 |
| 52-Week High | 330.88 |
| 52-Week Low | 206.19 |
| Moving Average 50 Days | 285.57 |
| Moving Average 200 Days | 266.53 |
Statistics
| Average Volume | 888,877 |
| Shares Outstanding | 70.65M |
| % Held by Institutions | 98.3 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.87 |
| Trailing Annual Dividend Yield | 0.28 |
| Payout Ratio | 0.11 |
| Last Split Factor | 2:1 |
| Last Split Date | September 27, 2013 |